Table 3.
Correlation between lncRNA SNHG12 expression and clinicopathologic parameters for cancers CI: confidence interval; DM: distant metastasis; LNM: lymph node metastasis; OR: odds ratio; SNHG12: small nucleolar RNA host gene 12; WHO grade: World Health Organization grade
| Heterogeneity |
||||||
|---|---|---|---|---|---|---|
| Clinicopathologic parameters |
No. of Studies |
No. of Participants |
Pooled OR (95% CI) | p-value | Model | Chi2, p-value, I2 (%) |
| Age (>60/≤60) | 3 | 191 | 0.93 (0.51, 1.70) | 0.81 | Fixed | 0.30, 0.86, 0 |
| Gender | 11 | 684 | 0.99 (0.73, 1.36) | 0.96 | Fixed | 4.86, 0.90, 0 |
| Tumor size (>5 cm/≤5 cm) | 4 | 272 | 5.05 (2.67, 9.55) | <0.001 | Fixed | 2.23, 0.53, 0 |
| LNM | 8 | 688 | 3.32 (2.32, 4.75) | <0.001 | Fixed | 12.20, 0.09, 43 |
| DM | 6 | 457 | 2.35 (1.46, 3.78) | <0.001 | Fixed | 9.00, 0.11, 44 |
| TNM stage | 8 | 583 | 3.61 (2.51, 5.17) | <0.001 | Fixed | 2.29, 0.94, 0 |
| WHO grade | 2 | 118 | 11.34 (4.60, 27.95) | <0.001 | Fixed | 0.30, 0.58, 0 |
| Gleason score (>7/≤7) | 2 | 255 | 2.69 (1.59, 4.53) | <0.001 | Fixed | 1.34, 0.25, 25 |